Wedge Capital Management L L P NC Purchases 32,831 Shares of Pediatrix Medical Group, Inc. (NYSE:MD)

Wedge Capital Management L L P NC lifted its stake in shares of Pediatrix Medical Group, Inc. (NYSE:MD) by 66.8% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 81,988 shares of the company’s stock after purchasing an additional 32,831 shares during the quarter. Wedge Capital Management L L P NC owned 0.10% of Pediatrix Medical Group worth $762,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Counterpoint Mutual Funds LLC purchased a new position in Pediatrix Medical Group during the third quarter worth about $84,000. Equita Financial Network Inc. purchased a new position in shares of Pediatrix Medical Group in the 3rd quarter worth about $128,000. AXQ Capital LP purchased a new position in shares of Pediatrix Medical Group in the 3rd quarter worth about $135,000. TD Asset Management Inc purchased a new position in shares of Pediatrix Medical Group in the 3rd quarter worth about $167,000. Finally, Corton Capital Inc. boosted its holdings in shares of Pediatrix Medical Group by 46.6% in the 3rd quarter. Corton Capital Inc. now owns 15,180 shares of the company’s stock worth $193,000 after purchasing an additional 4,828 shares in the last quarter. 97.71% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

MD has been the subject of a number of recent analyst reports. TheStreet lowered Pediatrix Medical Group from a “c” rating to a “d” rating in a research report on Friday, February 23rd. Jefferies Financial Group lowered their price target on Pediatrix Medical Group from $10.00 to $9.00 and set a “hold” rating for the company in a research report on Wednesday, March 6th. Truist Financial decreased their target price on Pediatrix Medical Group from $10.50 to $10.00 and set a “hold” rating for the company in a research report on Wednesday, February 21st. Finally, Mizuho cut their price target on Pediatrix Medical Group from $10.00 to $9.00 and set a “neutral” rating on the stock in a research note on Wednesday, February 21st. Five analysts have rated the stock with a hold rating, Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $10.30.

Pediatrix Medical Group Stock Down 3.8 %

MD stock opened at $8.89 on Friday. Pediatrix Medical Group, Inc. has a 1 year low of $7.70 and a 1 year high of $15.06. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.24 and a current ratio of 1.24. The stock’s fifty day moving average price is $9.21 and its 200-day moving average price is $9.64.

Pediatrix Medical Group (NYSE:MD) last posted its quarterly earnings results on Tuesday, February 20th. The company reported $0.32 EPS for the quarter, beating analysts’ consensus estimates of $0.30 by $0.02. The business had revenue of $496.44 million for the quarter, compared to analysts’ expectations of $524.30 million. Pediatrix Medical Group had a positive return on equity of 10.35% and a negative net margin of 3.03%. The business’s quarterly revenue was down 3.4% on a year-over-year basis. During the same period last year, the firm earned $0.46 earnings per share. Equities analysts anticipate that Pediatrix Medical Group, Inc. will post 1.12 earnings per share for the current year.

Pediatrix Medical Group Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.